What would get QLTI moving? Everyone seems to be spooked by "looming" competition from the likes of pfizer & genentech...
<< Data emerges next month from a phase II/III trial conducted by Eyetech and Pfizer (NYSE:PFE - News) using Macugen in patent's with age-related macular degeneration. Also on the horizon are results from Genentech (NYSE:DNA - News) and Alcon in 2004. >>